121.76
前日終値:
$123.53
開ける:
$123.23
24時間の取引高:
10.33M
Relative Volume:
1.65
時価総額:
$211.73B
収益:
$43.84B
当期純損益:
$13.90B
株価収益率:
15.27
EPS:
7.9725
ネットキャッシュフロー:
$6.92B
1週間 パフォーマンス:
-3.30%
1か月 パフォーマンス:
-4.02%
6か月 パフォーマンス:
-7.58%
1年 パフォーマンス:
+6.89%
Abbott Laboratories Stock (ABT) Company Profile
名前
Abbott Laboratories
セクター
電話
(224) 667-6100
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
ABT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-10 | 開始されました | The Benchmark Company | Buy |
| 2025-07-18 | アップグレード | Jefferies | Hold → Buy |
| 2025-06-16 | 開始されました | Leerink Partners | Market Perform |
| 2024-10-08 | 開始されました | Oppenheimer | Outperform |
| 2024-09-19 | 開始されました | Piper Sandler | Overweight |
| 2024-07-30 | ダウングレード | Edward Jones | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2023-07-21 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | 繰り返されました | Barclays | Overweight |
| 2023-04-20 | 繰り返されました | Bernstein | Outperform |
| 2023-04-20 | 繰り返されました | JP Morgan | Overweight |
| 2023-04-20 | 繰り返されました | Raymond James | Outperform |
| 2023-04-20 | 繰り返されました | UBS | Buy |
| 2023-04-20 | 繰り返されました | Wolfe Research | Underperform |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2022-10-26 | 開始されました | Mizuho | Neutral |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-07-06 | 開始されました | Wolfe Research | Underperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-01-27 | 繰り返されました | Credit Suisse | Outperform |
| 2022-01-27 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-01-27 | 繰り返されました | Raymond James | Outperform |
| 2022-01-27 | 繰り返されました | UBS | Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-10-27 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | 開始されました | Redburn | Neutral |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Neutral |
| 2021-01-28 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Outperform |
| 2020-06-01 | ダウングレード | Goldman | Neutral → Sell |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Neutral |
| 2020-01-02 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-06-13 | 繰り返されました | BofA/Merrill | Buy |
| 2019-02-07 | 繰り返されました | BofA/Merrill | Buy |
| 2019-01-02 | ダウングレード | Citigroup | Neutral → Sell |
| 2018-11-30 | アップグレード | Goldman | Neutral → Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-06-27 | 開始されました | Bernstein | Outperform |
| 2018-01-30 | 繰り返されました | Citigroup | Neutral |
| 2018-01-25 | 繰り返されました | Stifel | Buy |
| 2018-01-25 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2018-01-02 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-01-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-10-19 | 繰り返されました | Stifel | Buy |
すべてを表示
Abbott Laboratories (ABT) 最新ニュース
Abbott stock drops, ABT traders eye earnings after MLK Day shuts Wall Street - TechStock²
Abbott Laboratories: Who is the newcomer to Pōkeno? - BusinessDesk | NZ
Abbott Laboratories (ABT) positioned to benefit as healthcare sector enters recovery phase - MSN
Abbott Laboratories (ABT) Positioned to Benefit as Healthcare Sector Enters Recovery Phase - Yahoo Finance
Abbott Laboratories (NYSE:ABT) Stands Out as a Dependable Dividend Stock for Income Investors - Chartmill
Is Abbott Laboratories (ABT) Price Weakness Creating A Potential Opportunity Now? - Yahoo Finance
Abbott (ABT) Declines More Than Market: Some Information for Investors - Yahoo Finance Singapore
Options Corner: Abbott Laboratories Offer Economic Insulation Ahead Of Earnings - Benzinga
FDA confirms recalls for Abbott CGM sensors—new lawsuit alleges company concealed information - Cardiovascular Business
TorHoerman Law Announces $495 Million Jury Verdict in Case Involving Abbott Laboratories - ACCESS Newswire
1 Healthcare Stock to Consider Right Now and 2 We Find Risky - FinancialContent
Assessing Abbott Laboratories (ABT) Valuation After The CES 2026 Launch Of Libre Assist AI Tool - simplywall.st
Dividend King Abbott Shows Why 52 Consecutive Increases Weren’t Luck With Strong Cash Flow Coverage - AOL.com
Abbott reportedly looks to expand CGM manufacturing plant in Ireland - MassDevice
C-Reactive Protein Testing Market Is Going to Boom |• Abbott • Siemens Healthineers - openPR.com
Nordea Investment Management AB Buys 18,974 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Unloaded Rep. Julia Letlow - MarketBeat
Abbott Laboratories (ABT) Expected to Announce Earnings on Thursday - MarketBeat
Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories Target of Unusually Large Options Trading (NYSE:ABT) - MarketBeat
Retirement Planning Group LLC Grows Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stock Holdings Cut by Exencial Wealth Advisors LLC - MarketBeat
The Bull Case For Abbott Laboratories (ABT) Could Change Following Libre Assist AI Launch In Diabetes Care - simplywall.st
Gov't Didn't Allege Formula Was Contaminated, Abbott Says - Law360
ABT.SW Abbott Laboratories (SIX) volume spike 13 Jan 2026: CHF100 key - Meyka
Bernstein Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $154 - 富途牛牛
Why Abbott Laboratories (ABT) Story Is Shifting With Exact Sciences Deal Talk And Legal Wins - Yahoo Finance
Abbott, AtaCor Collaborate on Extravascular Implantable Cardioverter Defibrillator - Diagnostic and Interventional Cardiology
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know - Yahoo Finance
Abbott Laboratories (NYSE:ABT) Declares Quarterly Dividend of $0.63 - MarketBeat
MGO One Seven LLC Acquires 18,412 Shares of Abbott Laboratories $ABT - MarketBeat
Extracorporeal Membrane Oxygenation Machine Market Size to Hit USD 725.99 Million by 2033, Growing at a CAGR of 4.91% - GlobeNewswire Inc.
Abbott Laboratories (NYSE:ABT) is favoured by institutional owners who hold 80% of the company - Yahoo Finance
GRIMES & Co WEALTH MANAGEMENT LLC Purchases 10,635 Shares of Abbott Laboratories $ABT - MarketBeat
CPC Advisors LLC Grows Stock Holdings in Abbott Laboratories $ABT - MarketBeat
AbbVie reaches deal with Trump administration on drug prices in exchange for tariff relief - Chicago Tribune
Abbott Laboratories Stock: Quiet Grind Higher as Wall Street Warms to the Recovery Story - AD HOC NEWS
Abbott (ABT) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Institutional Investors Show Confidence in Abbott’s Healthcare Strategy - AD HOC NEWS
Is the Market Bullish or Bearish on Abbott Laboratories? - Benzinga
Abbott (ABT) Gains Ground in Glucose Monitoring Market - GuruFocus
Abbott, AtaCor collab on extravascular ICDs - MassDevice
Abbott Laboratories (ABT) Investor Outlook: Exploring a 14.95% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Abbott Laboratories $ABT Shares Acquired by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Biomedical and ICT Convergence Market Research Report 2025-2030: Opportunities in Developing Connected Medical Devices, Enhancing Precision Medicine, and Improving Healthcare Delivery - GlobeNewswire Inc.
Tema Etfs LLC Raises Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA - MarketBeat
Abbott Laboratories stock (ABT) in focus: Exact Sciences vote date lands as earnings week nears - TechStock²
Abbott Laboratories $ABT Shares Sold by New York State Teachers Retirement System - MarketBeat
Abbott Laboratories stock drifts into earnings after Canada widens Libre 3 Plus coverage - TechStock²
Parnassus Investments LLC Acquires New Shares in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories (ABT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):